No Detail Found!

Identification of Sulfamoylbenzamide derivatives as selective Cathepsin D inhibitors.

Author(s)
Waseem Ahmed Dr. Panjwani Center for Molecular Medicine and Drug Research, ICCBS, University of Karachi, Karachi, Pakistan; Department of Biochemistry, Fed. Urdu Univ. of Arts Sci. & Tech, Gulshan-e-Iqbal Campus, Karachi, Pakistan
Ishtiaq Ahmad Khan Dr. Panjwani Center for Molecular Medicine and Drug Research, ICCBS, University of Karachi, Karachi, Pakistan
Muhammad Nadeem Arshad GC University, Ketchery Road, Lahore, Pakistan
Waseeq Ahmad Siddiqui GC University, Ketchery Road, Lahore, Pakistan
Muhammad Abdul-Haleem Department of Biomedical Engineering, Sir Syed University of Technology, Karachi, Pakistan
Muhammad Kamran Azim Dr. Panjwani Center for Molecular Medicine and Drug Research, ICCBS, University of Karachi, Karachi, Pakistan
Abstract
Aspartic proteases play very important role in post translational processing of proteins and several of them are essential for organism’s viability. Here we present the enzyme inhibition activities of different Sulfamoylbenzamide derivatives against two aspartic proteases cathepsin D and plasmepsin II. Cathepsin D is an aspartic protease that degrades proteins at acidic pH in the lysosomes, or extracellular matrix. It is overexpressed by epithelial breast cancer cells and hence hyper-secreted. On the other hand plasmepsin II is an essential enzyme of Plasmodium falciperum. Cathepsin D and Plasmepsin II are pivotal drug targets for treatment of breast cancer and malaria respectively. Virtual screening of Sulfamoylbenzamide compounds followed by enzyme inhibition assays revealed these compounds as selective Cathepsin D inhibitors while inactive against Plasmepsin-II. IC50 values of five Sulfamoylbenzamide compounds tested are in range of 1.25-2.0 μM. N-(3-chlorophenyl)-2-sulfamoylbenzamide is identified as the most potent of all tested Sulfamoylbenzamide compounds with IC50 1.25 μM. It was also noted that the docking score of theses compounds was better in case of Cathepsin D as compared to Plasmepsin-II. Docking score ranges from -29.9±1.16 to -35.1±0.13 in case of Cathepsin D, while from -24.0±0.10 to -29.5±0.10 in case of Plasmepsin-II.
Publication Details
Page(s) 687-690
DOI DOI not available
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 26, Issue: 4, Year: 2013

Request the full text from PASTIC

0

Citations

0

Downloads

56

Views